Research

Medical Sciences

Title :

Combined Phase 2b/3, Double-Blind, Randomized, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Filgotinib in the Induction and Maintenance of Remission in Subjects with Moderately to sever active ulcerative colitis

Area of research :

Life Sciences & Biotechnology, Medical Sciences

Focus area :

Gastroenterology

Principal Investigator :

Dr Vineet Ahuja, Professor, All India Institute of Medical Sciences (AIIMS), New Delhi

Timeline Start Year :

2017

Timeline End Year :

2020

Contact info :

Details

Total Budget (INR):

 10,00,000

Organizations involved

Implementing Agency :

All India Institute of Medical Sciences (AIIMS), New Delhi

Funding Agency :

Gilead Sciences, Inc., USA

Related Research

A cross sectional investigation into the possible association between porphyromonas gingivalis strains isolated from the oral microbiome & oro-oesophageal cancer patients by MALDI-TOF MS & AP-PCR
A Long-Term Extension Study to Evaluate the Safety of Filgotinib in Subjects with Ulcerative Colitis
A phase III, randomized, double-blind, placebo controlled trial to evaluate the efficacy & safety of Vpm 1002 & immuvac vaccones in preventing Tuberculosis (TB) in healthy household contacts of newly diagnosed sputum positive pulmonary TB patients
A policy landscape and stakeholder analysis of a financial risk protection initiative in Odisha
Alloy development for additive manufacturing of prostheses and reconstructive implants (short name- MetAMeT Metal Additive Medical Technology)